Phase 4 Tuberculosis Trial, Recruiting (NCT07395596)

Phase 4 Tuberculosis Trial, Recruiting NCT07395596 Sponsor: First Affiliated Hospital of Zhejiang University Condition: Tuberculosis

Printed from Voxsanity (voxsanity.com.au) — NCT07395596 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Tuberculosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been classified by your doctor as having significant health conditions that pose moderate to high risk during procedures (known as ASA Class III or IV) (confirm with trial site)
You are already scheduled to have a planned, non-emergency bronchoscopy (a procedure to look inside the airways) done under sedation so you do not feel pain

Who may not be able to join:

You are under 18 years old
You are unable to cooperate with the medical team, for example due to a mental health condition
You regularly take opioid painkillers, sleeping tablets in the benzodiazepine family, or antidepressants on an ongoing basis
You have had an allergic reaction to anaesthetic (sedation or numbing) medicines in the past
Your doctor expects that managing your airway during the procedure may be difficult
Your body weight is either too low or too high for your height — specifically, your BMI is below 18.5 or above 30 (confirm with trial site)
Your blood oxygen level is below 92% when breathing normal room air before the procedure
The trial investigator has decided for any other reason that you are not suitable to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +8613777408863

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07395596

Sponsor: First Affiliated Hospital of Zhejiang University

Phase: Phase 4

Status: Recruiting

Condition: Tuberculosis

Trial contact: +8613777408863

More information: https://clinicaltrials.gov/study/NCT07395596

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been classified by your doctor as having significant health conditions that pose moderate to high risk during procedures (known as ASA Class III or IV) (confirm with trial site)
You are already scheduled to have a planned, non-emergency bronchoscopy (a procedure to look inside the airways) done under sedation so you do not feel pain

Who may not be able to join:

You are under 18 years old
You are unable to cooperate with the medical team, for example due to a mental health condition
You regularly take opioid painkillers, sleeping tablets in the benzodiazepine family, or antidepressants on an ongoing basis
You have had an allergic reaction to anaesthetic (sedation or numbing) medicines in the past
Your doctor expects that managing your airway during the procedure may be difficult
Your body weight is either too low or too high for your height — specifically, your BMI is below 18.5 or above 30 (confirm with trial site)
Your blood oxygen level is below 92% when breathing normal room air before the procedure
The trial investigator has decided for any other reason that you are not suitable to take part

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

First Affiliated Hospital of Zhejiang University

Registry

ClinicalTrials.gov

Start date

9 February 2026

Est. completion

1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The incidence of hypoxia（75% ≤ SpO2 < 90% for <60 s）

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov